Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

RNA editing modulates the binding of drugs and highly unsaturated fatty acids to the open pore of Kv potassium channels.

Decher N, Streit AK, Rapedius M, Netter MF, Marzian S, Ehling P, Schlichthörl G, Craan T, Renigunta V, Köhler A, Dodel RC, Navarro-Polanco RA, Preisig-Müller R, Klebe G, Budde T, Baukrowitz T, Daut J.

EMBO J. 2010 Jul 7;29(13):2101-13. doi: 10.1038/emboj.2010.88. Epub 2010 May 11.

2.

Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.

Decher N, Kumar P, Gonzalez T, Renigunta V, Sanguinetti MC.

Mol Pharmacol. 2005 Oct;68(4):995-1005. Epub 2005 Jul 15.

3.

Novel alpha-KTx sites in the BK channel and comparative sequence analysis reveal distinguishing features of the BK and KV channel outer pore.

Giangiacomo KM, Becker J, Garsky C, Schmalhofer W, Garcia ML, Mullmann TJ.

Cell Biochem Biophys. 2008;52(1):47-58. doi: 10.1007/s12013-008-9026-3. Epub 2008 Sep 25.

PMID:
18815746
4.

Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels.

Decher N, Pirard B, Bundis F, Peukert S, Baringhaus KH, Busch AE, Steinmeyer K, Sanguinetti MC.

J Biol Chem. 2004 Jan 2;279(1):394-400. Epub 2003 Oct 25.

5.

Identification of residues in dendrotoxin K responsible for its discrimination between neuronal K+ channels containing Kv1.1 and 1.2 alpha subunits.

Wang FC, Bell N, Reid P, Smith LA, McIntosh P, Robertson B, Dolly JO.

Eur J Biochem. 1999 Jul;263(1):222-9.

6.

Kv beta subunit oxidoreductase activity and Kv1 potassium channel trafficking.

Campomanes CR, Carroll KI, Manganas LN, Hershberger ME, Gong B, Antonucci DE, Rhodes KJ, Trimmer JS.

J Biol Chem. 2002 Mar 8;277(10):8298-305. Epub 2001 Dec 17.

7.

Control of voltage-gated K+ channel permeability to NMDG+ by a residue at the outer pore.

Wang Z, Wong NC, Cheng Y, Kehl SJ, Fedida D.

J Gen Physiol. 2009 Apr;133(4):361-74. doi: 10.1085/jgp.200810139.

8.

Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.

Zhang ZH, Lee YT, Rhodes K, Wang K, Argentieri TM, Wang Q.

Brain Res Mol Brain Res. 2003 Jul 4;115(1):29-38.

PMID:
12824052
9.

Kinetic modulation of Kv4-mediated A-current by arachidonic acid is dependent on potassium channel interacting proteins.

Holmqvist MH, Cao J, Knoppers MH, Jurman ME, Distefano PS, Rhodes KJ, Xie Y, An WF.

J Neurosci. 2001 Jun 15;21(12):4154-61.

10.

Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels.

Kurata HT, Soon GS, Eldstrom JR, Lu GW, Steele DF, Fedida D.

J Biol Chem. 2002 Aug 9;277(32):29045-53. Epub 2002 May 20.

11.

Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kvbeta subunits.

Bähring R, Milligan CJ, Vardanyan V, Engeland B, Young BA, Dannenberg J, Waldschutz R, Edwards JP, Wray D, Pongs O.

J Biol Chem. 2001 Jun 22;276(25):22923-9. Epub 2001 Apr 9.

12.

RNA editing in eag potassium channels: biophysical consequences of editing a conserved S6 residue.

Ryan MY, Maloney R, Fineberg JD, Reenan RA, Horn R.

Channels (Austin). 2012 Nov-Dec;6(6):443-52. doi: 10.4161/chan.22314. Epub 2012 Oct 12.

13.

Mutations in the Kv beta 2 binding site for NADPH and their effects on Kv1.4.

Peri R, Wible BA, Brown AM.

J Biol Chem. 2001 Jan 5;276(1):738-41.

14.

Functional characterization of Kv channel beta-subunits from rat brain.

Heinemann SH, Rettig J, Graack HR, Pongs O.

J Physiol. 1996 Jun 15;493 ( Pt 3):625-33.

15.

Effects of intracellular magnesium on Kv1.5 and Kv2.1 potassium channels.

Tammaro P, Smirnov SV, Moran O.

Eur Biophys J. 2005 Feb;34(1):42-51. Epub 2004 Jul 8.

PMID:
15243721
16.

KChAP/Kvbeta1.2 interactions and their effects on cardiac Kv channel expression.

Kuryshev YA, Wible BA, Gudz TI, Ramirez AN, Brown AM.

Am J Physiol Cell Physiol. 2001 Jul;281(1):C290-9.

17.

RNA editing in the central cavity as a mechanism to regulate surface expression of the voltage-gated potassium channel Kv1.1.

Streit AK, Matschke LA, Dolga AM, Rinné S, Decher N.

J Biol Chem. 2014 Sep 26;289(39):26762-71. doi: 10.1074/jbc.M113.545731. Epub 2014 Aug 6.

18.
19.

Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.

Madeja M, Leicher T, Friederich P, Punke MA, Haverkamp W, Musshoff U, Breithardt G, Speckmann EJ.

Mol Pharmacol. 2003 Mar;63(3):547-56.

20.

A novel beta subunit increases rate of inactivation of specific voltage-gated potassium channel alpha subunits.

Morales MJ, Castellino RC, Crews AL, Rasmusson RL, Strauss HC.

J Biol Chem. 1995 Mar 17;270(11):6272-7.

Items per page

Supplemental Content

Write to the Help Desk